Advertisement
Research Article

Variation in MSRA Modifies Risk of Neonatal Intestinal Obstruction in Cystic Fibrosis

  • Lindsay B. Henderson,

    Affiliation: McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

    X
  • Vishal K. Doshi,

    Affiliation: McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

    X
  • Scott M. Blackman,

    Affiliations: McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America, Division of Pediatric Endocrinology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

    X
  • Kathleen M. Naughton,

    Affiliation: McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

    X
  • Rhonda G. Pace,

    Affiliation: Cystic Fibrosis/Pulmonary Research and Treatment Center, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America

    X
  • Jackob Moskovitz,

    Affiliation: Department of Pharmacology and Toxicology, University of Kansas, Lawrence, Kansas, United States of America

    X
  • Michael R. Knowles,

    Affiliation: Cystic Fibrosis/Pulmonary Research and Treatment Center, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America

    X
  • Peter R. Durie,

    Affiliations: Division of Gastroenterology, Hepatology, and Nutrition, Hospital for Sick Children, Toronto, Canada, Department of Pediatrics, University of Toronto, Toronto, Canada

    X
  • Mitchell L. Drumm,

    Affiliation: Departments of Pediatrics and Genetics, Case Western Reserve University, Cleveland, Ohio, United States of America

    X
  • Garry R. Cutting mail

    gcutting@jhmi.edu

    Affiliation: McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

    X
  • Published: March 15, 2012
  • DOI: 10.1371/journal.pgen.1002580

About the Authors

Lindsay B. Henderson, Vishal K. Doshi, Scott M. Blackman, Kathleen M. Naughton, Garry R. Cutting
McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America
Scott M. Blackman
Division of Pediatric Endocrinology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America
Rhonda G. Pace, Michael R. Knowles
Cystic Fibrosis/Pulmonary Research and Treatment Center, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America
Jackob Moskovitz
Department of Pharmacology and Toxicology, University of Kansas, Lawrence, Kansas, United States of America
Peter R. Durie
Division of Gastroenterology, Hepatology, and Nutrition, Hospital for Sick Children, Toronto, Canada
Peter R. Durie
Department of Pediatrics, University of Toronto, Toronto, Canada
Mitchell L. Drumm
Departments of Pediatrics and Genetics, Case Western Reserve University, Cleveland, Ohio, United States of America

Corresponding Author

Email: gcutting@jhmi.edu

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

Conceived and designed the experiments: LBH VKD SMB MLD GRC. Performed the experiments: LBH VKD. Analyzed the data: LBH VKD MLD GRC. Contributed reagents/materials/analysis tools: KMN RGP JM MRK PRD MLD GRC. Wrote the paper: LBH GRC.